399 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Lifestyle Asset Management Inc.

Lifestyle Asset Management Inc. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 399 shares of the healthcare conglomerate’s stock, valued at approximately $209,000.

Other large investors also recently bought and sold shares of the company. Waycross Partners LLC boosted its stake in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after acquiring an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $515,000. Full Sail Capital LLC boosted its stake in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares in the last quarter. Soros Fund Management LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $39,413,000. Finally, Silvercrest Asset Management Group LLC raised its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after buying an additional 12,550 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $300.37 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a market capitalization of $272.48 billion, a price-to-earnings ratio of 19.38, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm’s fifty day moving average price is $418.00 and its 200 day moving average price is $488.12.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the firm earned $6.91 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Piper Sandler reduced their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a report on Tuesday. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. KeyCorp cut their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a report on Monday. Mizuho cut their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Finally, Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $428.43.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.